Bosello, Silvia Laura
 Distribuzione geografica
Continente #
EU - Europa 2.858
NA - Nord America 2.752
AS - Asia 756
AF - Africa 16
OC - Oceania 12
SA - Sud America 10
Continente sconosciuto - Info sul continente non disponibili 9
Totale 6.413
Nazione #
US - Stati Uniti d'America 2.738
DE - Germania 912
SE - Svezia 470
IT - Italia 468
CN - Cina 393
UA - Ucraina 226
FR - Francia 224
IE - Irlanda 177
SG - Singapore 150
IN - India 101
GB - Regno Unito 99
RU - Federazione Russa 74
PL - Polonia 68
FI - Finlandia 59
TR - Turchia 45
BE - Belgio 34
IR - Iran 20
HK - Hong Kong 19
CA - Canada 13
AU - Australia 12
CI - Costa d'Avorio 11
JP - Giappone 11
CZ - Repubblica Ceca 8
RO - Romania 8
NL - Olanda 7
ES - Italia 6
EU - Europa 6
DK - Danimarca 5
KR - Corea 5
CO - Colombia 4
A2 - ???statistics.table.value.countryCode.A2??? 3
BR - Brasile 3
CH - Svizzera 3
MY - Malesia 3
NG - Nigeria 3
BG - Bulgaria 2
CL - Cile 2
HU - Ungheria 2
SA - Arabia Saudita 2
SI - Slovenia 2
AE - Emirati Arabi Uniti 1
AR - Argentina 1
BA - Bosnia-Erzegovina 1
BD - Bangladesh 1
BY - Bielorussia 1
BZ - Belize 1
CY - Cipro 1
EG - Egitto 1
GE - Georgia 1
LU - Lussemburgo 1
MD - Moldavia 1
PK - Pakistan 1
TH - Thailandia 1
TW - Taiwan 1
UG - Uganda 1
Totale 6.413
Città #
Chandler 590
Ashburn 214
Dublin 176
Ann Arbor 173
Jacksonville 132
Dearborn 121
San Mateo 96
Singapore 95
Wilmington 88
Woodbridge 84
Nanjing 82
New York 80
Houston 72
Seattle 68
Milan 66
Kraków 64
Rome 62
Fairfield 61
Moscow 56
Nürnberg 48
Boston 46
Lawrence 42
Marseille 42
Beijing 40
Izmir 39
Cattolica 37
Bremen 34
Munich 34
Nanchang 34
Brussels 33
Pune 31
Redwood City 28
Princeton 25
Hebei 23
Norwalk 23
Kunming 20
Boardman 18
Guangzhou 18
Lancaster 17
Leawood 16
Tianjin 16
Trieste 16
Augusta 15
Cambridge 15
Falls Church 15
Fremont 15
Hong Kong 14
Andover 13
Chicago 13
Detroit 12
Abidjan 11
Helsinki 11
Mountain View 11
Redmond 11
University Park 11
Hangzhou 10
Jiaxing 10
Shenyang 9
Zhengzhou 9
Changsha 8
Florence 8
Kish 8
Los Angeles 8
Hefei 7
London 7
Shanghai 7
Monmouth Junction 6
Paris 6
Ardabil 5
Brno 5
Busto Arsizio 5
Ferrara 5
Fuzhou 5
Palermo 5
Rozzano 5
Seoul 5
Tokyo 5
Toronto 5
Changchun 4
Enterprise 4
Jinan 4
Phoenix 4
Rivignano 4
Toowoomba 4
Washington 4
Atlanta 3
Bologna 3
Campolongo Maggiore 3
Central 3
Chengdu 3
Clearwater 3
Copenhagen 3
Frankfurt am Main 3
Hounslow 3
Kuala Lumpur 3
Lagos 3
Lanzhou 3
Lappeenranta 3
Melbourne 3
Nancy 3
Totale 3.453
Nome #
The prognostic significance of the Birmingham Vasculitis Activity Score (BVAS) with systemic vasculitis patients transferred to the intensive care unit (ICU) 319
B CELL DEPLETION IN DIFFUSE PROGRESSIVE SYSTEMIC SCLEROSIS: SAFETY, SKIN SCORE MODIFICATION AND IL-6 MODULATION IN AN UP TO THIRTY-SIX MONTHS FOLLOW-UP OPEN-LABEL TRIAL 234
B cell subsets in the joint compartments of seropositive and seronegative RA and non-RA arthritides express memory markers and ZAP-70 and characterize the aggregate pattern irrespectively of the autoantibody status. 186
Impatto dell’inquinamento ambientale da benzene e PM10 sulla progressione clinica della sclerosi sistemica: un’analisi di correlazione. 176
Synovial fluid-derived T helper 17 cells correlate with inflammatory activity in arthritis, irrespectively of diagnosis. 162
MR imaging of atlantoaxial joint in early rheumatoid arthritis. 158
Recognizing and treating myocarditis in recent-onset systemic sclerosis heart disease: Potential utility of immunosuppressive therapy in cardiac damage progression 137
Proteomic approaches to Sjögren's syndrome: a clue to interpret the pathophysiology and organ involvement of the disease. 132
Asthma in patients admitted to emergency department for COVID-19: prevalence and risk of hospitalization 132
Atlantoepistrophic magnetic resonance imaging involvement in early rheumatoid arthritis: an aggressive tight control therapy not fully arresting the disease 129
A vascular endothelial growth factor deficiency characterises scleroderma lung disease 127
Very early rheumatoid arthritis is the major predictor of major outcome: clinical ACR remission and radiographic non-progression. 125
beta-thymosins and interstitial lung disease: study of a scleroderma cohort with a one-year follow-up 120
B CELLS IN SYSTEMIC SCLEROSIS: A POSSIBLE TARGET FOR THERAPY 117
Memory B cell subsets and plasmablasts are lower in early than in long-standing rheumatoid arthritis 114
Assessment of neurological manifestations in hospitalized patients with COVID-19 112
Detection of bone erosions in early rheumatoid arthritis: 3D ultrasonography versus computed tomography 111
(AS) TNF-alpha blockade induces a reversible but transient effect on endothelial dysfunction in patients with long-standing severe rheumatoid arthritis. 109
Long-term efficacy of B cell depletion therapy on lung and skin involvement in diffuse systemic sclerosis 109
Allele *2 of the HS1,2A enhancer of the Ig regulatory region associates with rheumatoid arthritis 106
Preserved cardiorespiratory function and NT-proBNP levels before and during exercise in patients with recent onset of rheumatoid arthritis: the clinical challenge of stratifying the patient cardiovascular risks 106
ENVIRONMENTAL POLLUTION AND SYSTEMIC SCLEROSIS: A PILOT STUDY ON BENZENE AND PARTICULATE EXPOSURE AS RISK FACTORS FOR THE SYSTEMIC MANIFESTATIONS 104
Proteome analysis of biological fluids from autoimmune-rheumatological disorders 103
Prognostic Role of Ventricular Ectopic Beats in Systemic Sclerosis: A Prospective Cohort Study Shows ECG Indexes Predicting the Worse Outcome 102
Tumour-associated antigens in systemic sclerosis patients with interstitial lung disease: association with lung involvement and cancer risk 99
Clinical and ultrasonographic remission determines different chances of relapse in early and long standing rheumatoid arthritis. 95
Prognostic Role of Ventricular Ectopic Beats in Systemic Sclerosis: A Prospective Cohort Study Shows ECG Indexes Predicting the Worse Outcome 94
Bronchoalveolar lavage fluid and progression of scleroderma interstitial lung disease 92
Environmental pollution and systemic sclerosis manifestations: a pilot study on benzene and particulate exposure 81
Tumour-associated antigens in systemic sclerosis patients with interstitial lung disease: association with lung involvement and cancer risk 81
Quantitative and semi-quantitative computed tomography analysis of interstitial lung disease associated with systemic sclerosis: A longitudinal evaluation of pulmonary parenchyma and vessels 81
Life-threatening arrhythmias in a scleroderma patient: the role of myocardial inflammation in arrhythmic outburst 80
Preserved cardiorespiratory function and NT-proBNP levels before and during exercise in patients with recent onset of rheumatoid arthritis: the clinical challenge of stratifying the patient cardiovascular risks 79
Improved Endothelial Function After Endothelin Receptor Blockade in Patients With Systemic Sclerosis 78
Baseline shoulder ultrasonography is not a predictive marker of response to glucocorticoids in patients with polymyalgia rheumatica: A 12-month followup study 78
Recognizing and treating myocarditis in recent-onset systemic sclerosis heart disease: potential utility of immunosuppressive therapy in cardiac damage progression 74
Characterization of inflammatory cell infiltrate of scleroderma skin: B cells and skin score progression. 73
Cardiac troponin T and NT-proBNP as diagnostic and prognostic biomarkers of primary cardiac involvement and disease severity in systemic sclerosis: A prospective study 71
Very early rheumatoid arthritis as a predictor of remission: a multicentre real life prospective study 68
The human salivary proteome: a critical overview of the results obtained by different proteomic platforms 68
Sarilumab use in severe SARS-CoV-2 pneumonia 68
Immunosuppressive Therapy (Methotrexate or Cyclophosphamide) in Combination with Corticosteroids in the Treatment of Giant Cell Arteritis: Comparison with Corticosteroids Alone 67
Thymosin β4 and β10 in Sjögren's syndrome: Saliva proteomics and minor salivary glands expression 67
No higher risk of respiratory symptoms in Italian rheumatological patients under IL-6R-inhibitor therapy in SARS-CoV-2 pandemic 64
Adult-onset Still's disease following COVID-19 vaccination 63
Bronchoalveolar lavage fluid and progression of scleroderma interstitial lung disease 62
Interleukin-6 and IgA-rheumatoid factor are crucial for baseline erosiveness, and anti-citrullinated peptide antibodies for radiographic progression in early rheumatoid arthritis treated according to a treat-to-target strategy 61
Free light chains of immunoglobulins in patients with systemic sclerosis: correlations with lung involvement and inflammatory milieu 60
Adult Onset Still's Disease and Radiotherapy treatment for breast cancer: Case report about management of this rare association and literature review 59
Computer-aided quantification of interstitial lung disease from high resolution computed tomography images in systemic sclerosis: correlation with visual reader-based score and physiologic tests 57
Troponin in Stable Ischemic Heart Disease and Diabetes 54
Troponin in Stable Ischemic Heart Disease and Diabetes 53
FUNZIONE CARDIORESPIRATORIA, ARTERIAL STIFFNESS E LIVELLI DI NT-PRO BNP IN PAZIENTI AFFETTI DA ARTRITE REUMATOIDE ALL’ESORDIO 50
No higher risk of respiratory symptoms in Italian rheumatological patients under IL-6R-inhibitor therapy in SARS-CoV-2 pandemic 50
An unusual lung involvement in scleroderma: lipoid pneumonia 50
Subclinical atherosclerosis and endothelial dysfunction in patients with polymyalgia rheumatica: a pilot study 48
Gut microbiota analysis in systemic sclerosis according to disease characteristics and nutritional status 48
Very early rheumatoid arthritis as a predictor of remission: a multicentre real life prospective study 46
Microvascular heart involvement in systemic autoimmune diseases: The purinergic pathway and therapeutic insights from the biology of the diseases 46
Arthritis in systemic vasculitis: a retrospective analysis 45
Sixth-month remission as a predictor for twelve-month remission in polymyalgia rheumatica 43
Treatment strategy introducing immunosuppressive drugs with glucocorticoids ab initio or very early in giant cell arteritis: A multicenter retrospective controlled study 39
Ecografia delle spalle in pazienti con PR: valore diagnostico ma non predittivo 36
Measuring the T-cell down-regulation of TCR-zeta, ZAP-70 and CD28 in arthritis patients: An old tool for new biomarkers 36
Long-term efficacy of B cell depletion therapy on lung and skin involvement in diffuse systemic sclerosis 36
Multidisciplinary Evaluation of Interstitial Lung Diseases: New Opportunities Linked to Rheumatologist Involvement 35
Chronic related group classification system as a new public health tool to predict risk and outcome of COVID-19 in patients with systemic rheumatic diseases: A population-based study of more than forty thousand patients 32
Reply to: Individuality of the composition of the human microbiota 31
The role of PET/CT in connective tissue disorders: systemic sclerosis, Sjögren's syndrome and systemic lupus erythematosus 27
Sudden winter iloprost withdrawal in scleroderma patients during COVID-19 pandemic 20
Sixth-month remission as a predictor for twelve-month remission in polymyalgia rheumatica 20
The role of PET/CT in connective tissue disorders: systemic sclerosis, Sjögren's syndrome and systemic lupus erythematosus 20
Extension of Lung Damage at Chest Computed Tomography in Severely Ill COVID-19 Patients Treated with Interleukin-6 Receptor Blockers Correlates with Inflammatory Cytokines Production and Prognosis 19
What can we learn from rapidly progressive interstitial lung disease related to anti-MDA5 dermatomyositis in the management of COVID-19? 19
Lung ultrasound predicts non-invasive ventilation outcome in COVID-19 acute respiratory failure: a pilot study 17
Survival and prognostic factors from a multicentre large cohort of unselected Italian systemic sclerosis patients 16
Sex-related Differences in Systemic Sclerosis: A Multicenter Cross-sectional Study From the National Registry of the Italian Society for Rheumatology 16
Prevalence and Death Rate of COVID-19 in Autoimmune Systemic Diseases in the First Three Pandemic Waves. Relationship with Disease Subgroups and Ongoing Therapies 16
Lung vascular changes as biomarkers of severity in systemic sclerosis-associated interstitial lung disease 14
Letter: prevalence and patterns of gastrointestinal symptoms in a large Western cohort of patients with COVID-19 13
Environmental Pollution by Benzene and PM10 and Clinical Manifestations of Systemic Sclerosis: A Correlation Study 13
Risk of burnout and stress in physicians working in a COVID team: A longitudinal survey 13
Systemic sclerosis progression INvestiGation (SPRING) Italian registry: Demographic and clinico-serological features of the scleroderma spectrum 12
Ultrasonography involvement of carotid, upper and lower limb arteries in a large cohort of systemic sclerosis patients 12
COVID-19 and intestinal inflammation: Role of fecal calprotectin 12
Preserved cardiorespiratory function and NT-proBNP levels before and during exercise in patients with recent onset of rheumatoid arthritis: the clinical challenge of stratifying the patient cardiovascular risks 11
Real-life efficacy and safety of nintedanib in systemic sclerosis-interstitial lung disease: data from an Italian multicentre study 11
COVID-19 and RA share an SPP1 myeloid pathway that drives PD-L1+ neutrophils and CD14+ monocytes 11
Interleukin-6 and IgA-rheumatoid factor are crucial for baseline erosiveness, and anti-citrullinated peptide antibodies for radiographic progression in early rheumatoid arthritis treated according to a treat-to-target strategy 11
More to B: the growing evidence to inform targeting B cells in scleroderma 11
COVID-19 and RA share an SPP1 myeloid pathway that drives PD-L1+ neutrophils and CD14+ monocytes 11
Comment on: Skin improvement is a surrogate for favourable changes in other organ systems in early diffuse cutaneous systemic sclerosis 10
Interstitial Lung Disease Associated With Autoimmune Rheumatic Diseases: Checklists for Clinical Practice 10
Covid-19 And Rheumatic Autoimmune Systemic Diseases: Role of Pre-Existing Lung Involvement and Ongoing Treatments 10
Diagnostic performance of anti-citrullinated peptide antibodies for the diagnosis of rheumatoid arthritis: the relevance of likelihood ratios 10
Gemelli decision tree Algorithm to Predict the need for home monitoring or hospitalization of confirmed and unconfirmed COVID-19 patients (GAP-Covid19): preliminary results from a retrospective cohort study 10
Correspondence to 'Gender gap in rheumatology: speaker representation at annual conferences' by Monga and Liew-gender discrepancies at annual EULAR congresses: towards the gap narrowing 9
PTPN22 1858C>T polymorphism distribution in Europe and association with rheumatoid arthritis: case-control study and meta-analysis 9
Geographical heterogeneity of clinical and serological phenotypes of systemic sclerosis observed at tertiary referral centres. The experience of the Italian SIR-SPRING registry and review of the world literature 8
Synovial B cells of rheumatoid arthritis express ZAP-70 which increases the survival and correlates with the inflammatory and autoimmune phenotype 8
Totale 6.457
Categoria #
all - tutte 28.163
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 28.163


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020827 131 42 48 29 72 128 79 30 30 63 124 51
2020/2021747 29 54 197 49 87 21 51 20 87 28 107 17
2021/2022800 54 38 23 56 61 44 36 102 39 86 106 155
2022/20231.685 214 235 127 271 83 191 83 138 152 14 56 121
2023/20241.067 36 278 53 57 38 146 73 76 21 31 149 109
2024/202541 41 0 0 0 0 0 0 0 0 0 0 0
Totale 6.581